Here are relevant reports on : animal-prebiotics-market
-
Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Swine, Poultry, Ruminant, Aquaculture), Form (Dry and Liquid), Function (Nutrition & Gut Health, Yield, Immunity, Production) - Global Forecast to 2022
The eubiotics market is projected to grow at a CAGR of 7.51% to reach USD 7.47 Billion by 2022. The market is driven by factors such as increase in awareness about feed quality and safety, rise in demand for manufactured animal feed, growth in demand for animal high protein, change in framing practices and technology, and replacing antibiotic growth promoters (AGPs) with eubiotics. Continuous rise in the population also results in increase in the demand for food and the necessity for eubiotics, to increase the meat and milk in a sustainable manner.
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
Nutraceutical Products Market Size, Share & Trends Analysis Report by Type (Food, Beverages, Dietary Supplements), Source (Probiotics, Prebiotics, Vitamins, Minerals), Distribution Channel (Conventional Stores, Specialty Stores, Drugstores & Pharmacies), Region - Global Forecast to 2025
The nutraceutical products market is expected to grow from USD 267.4 billion in 2019 to USD 404.8 billion by 2025, at a compound annual growth rate (CAGR) of 7.2% during the forecast period.The nutraceutical products market is projected to reach USD 404.8 billion by 2025 and was estimated at USD 267.4 billion in 2019, recording a CAGR of 7.2% from 2019. Key factors driving the nutraceutical products market include the increasing aging population and focus on preventive healthcare. In addition, increasing mandates pertaining to food fortification by government organizations is projected to reflect positively on the market growth.
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Pork Feed & Feed Additive Market By Types (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Acidifiers) By Ancillary Supplements (Prebiotics and Probiotics), Trends & Forecast 2013-2018
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Digestive Health Ingredients Market, By Type (Digestive Enzymes, Probiotics, Prebiotics, Zinc Carnosine) By Application (Beverages, Bakery, Dairy and Others) By Geography
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Medicated Feed Additives Market by Type (Antioxidants, Antibiotics, Probiotics & Prebiotics, Enzymes, Amino Acids), Livestock (Ruminants, Poultry, Swine, Aquaculture), Mixture Type, Category, and Region - Global Forecast to 2022
The medicated feed additives market is projected to grow at a CAGR of 5.41% from 2016, to reach USD 15.32 Billion by 2022. The growing global population and rise in disposable income drives meat consumption growth over the forecast period in developing countries thereby increasing the growth of the medicated feed additives market. Medicated feed additives offer several advantages to producers. Increase in awareness of high-quality meat, which is rich in nutrients, has resulted in an increase in the usage of medicated feed additives.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Infant Formula Ingredients Market by Ingredient Type (Carbohydrates, Oils & Fats, Proteins, Vitamins, Minerals, Prebiotics), Application (Growing-up Milk, Standard Infant Formula, Follow-on Formula, Specialty), Form, Source, Region-Global Forecast to 2025
The global infant formula ingredients market by size was estimated at USD 16.7 billion in 2019 and anticipated to hit USD 25.5 billion by 2025, growing at a CAGR of 7.3%.. This report includes a study of marketing and development strategies along with the product portfolios of leading companies in the sodium hypophosphite market. It consists of the profiles of leading companies such as AAK AB (Sweden), Fonterra Co-operative Group Limited (New Zealand), Carbery Food Ingredients Limited (Ireland), Royal Friesland Campina N.V. (Netherlands), Sachsenmilch Leppersdorf GmbH (Germany), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Arla Foods amba (Denmark), Chr. Hansen Holdings A/S (Denmark), Kerry Group plc (Ireland), Lactalis Ingredients (France), Glanbia plc (Ireland), and Vitablend Nederland B.V. (Netherlands).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Functional Food Ingredients Market by Type (Probiotics, Protein & Amino Acids, Phytochemicals & Plant Extracts, Prebiotics, Omega-3 Fatty Acids, Carotenoids, Vitamins), Application, Source, Form, Health Benefits and Region - Global Forecast to 2029
The global functional food ingredients market size is projected to reach USD 119.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 6.8% during the forecasting period. The key players in this market include Cargill, Incorporated (US), BASF SE (Germany), ADM (US), International Flavors & Fragrances Inc. (US), Arla Foods amba (Denmark), Kerry Group plc (Ireland), Ajinomoto Co., Inc. (Japan), DSM (Netherlands), Ingredion (US), Tate & Lyle (UK), and TEIJIN LIMITED (Japan).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031
The global human microbiome market, valued at USD 0.91 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. The growth of the Europe human microbiome market is driven by increased awareness of personalized health, the adoption of microbiome-based therapies, and advancements in sequencing technologies and bioinformatics.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
